Sanofi Applauds Supreme Court Ruling Supporting Scientific Innovation by Striking Down Amgen’s Asserted PCSK9 Patent Claims in Amgen v Sanofi

Decision unanimously affirms the United States Federal Circuit Court’s opinion that Amgen’s asserted U.S. PCSK9 patent claims are invalid BRIDGEWATER, N.J., May 18, 2023 /PRNewswire/ — Sanofi (NASDAQ: SNY) is pleased with the United States Supreme Court’s ruling in Amgen v. Sanofi et. al….